The use of “rt-pa” for the treatment of sudden and “chronic hearing loss”
Eighty patients with sudden hearing loss and seventy patients with a chronical cochlear function decreasing have been treated until now with intravenous infusion of a recombinant glycoprotein analogous tissutal plasminogen activator (rt-PA): 3mg dissolved in 250mg of physiological saline given every 12 hr intravenously. Specifically excluded were patients with abnormal known coagulation. No patient was […]
